Characterization of CD133+/CD44+ human prostate cancer stem cells with ATR-FTIR spectroscopy

Analyst, 2019, Accepted Manuscript DOI: 10.1039/C9AN00093C, PaperG ünnur Güler, Ümmü Güven, Gülperi Öktem Current cancer treatments destroy the tumor mass but can not prevent the recurrence of cancer. Heterogeneous structure of tumor mass includes cancer stem cells that are responsible for tumor relapse,... The content of this RSS Feed (c) The Royal Society of Chemistry

Source: RSC - Analyst latest articles - January 29, 2019 Category: Chemistry Authors: G ünnur Güler Source Type: research